Mitochondria remodeling in cancer

Kenneth J. Dornfeld, Andrew J Skildum

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Cancer cells are characterized by altered metabolism and uncontrolled proliferation. It is not surprising that mitochondria, which serve important roles in fuel oxidation (catabolism) and synthesizing biosynthetic precursors (anabolism), are altered in cancer cells. Although most cancer cells have increased uptake of glucose and upregulation of glycolysis, mitochondria remain essential for carcinogenesis. However, cancer cell mitochondria have significant differences that distinguish them from those of normal cells. Mitochondria of cancer cells often have decreased electron transport capacity, depressed ATP generation, and increased production of reactive oxygen species. These alterations in metabolism promote nutrient uptake, support increased proliferation and afford resistance to apoptotic cell death. The specific metabolic processes in cancer provide opportunities to selectively target them pharmacologically to improve outcomes for cancer patients. In cancer diagnosis, tumor metabolism can be inferred from gene expression patterns and mutations, rates of nutrient uptake, and from direct measurement of metabolites. In treatment, these processes can be specifically targeted. Alterations in metabolism, mitochondrial DNA, the electron transport chain, and tricarboxylic acid cycle enzymes in cancer are described. The exploitation of these differences for diagnosis and treatment are discussed, with a review of select agents currently in clinical use or under active investigation.

Original languageEnglish (US)
Title of host publicationMitochondrial Biology and Experimental Therapeutics
PublisherSpringer International Publishing
Pages153-191
Number of pages39
ISBN (Electronic)9783319733449
ISBN (Print)9783319733432
DOIs
StatePublished - Mar 21 2018

Fingerprint

Mitochondria
Metabolism
Cells
Neoplasms
Nutrients
Cell death
Electron Transport
Metabolites
Mitochondrial DNA
Gene expression
Tumors
Reactive Oxygen Species
Adenosine Triphosphate
Glucose
Oxidation
Citric Acid Cycle
Glycolysis
Mutation Rate
Enzymes
Carcinogenesis

Keywords

  • Anabolism
  • Cancer
  • Chemotherapy
  • Glycolysis
  • Tricarboxylic acid cycle
  • Warburg

Cite this

Dornfeld, K. J., & Skildum, A. J. (2018). Mitochondria remodeling in cancer. In Mitochondrial Biology and Experimental Therapeutics (pp. 153-191). Springer International Publishing. https://doi.org/10.1007/978-3-319-73344-9_9

Mitochondria remodeling in cancer. / Dornfeld, Kenneth J.; Skildum, Andrew J.

Mitochondrial Biology and Experimental Therapeutics. Springer International Publishing, 2018. p. 153-191.

Research output: Chapter in Book/Report/Conference proceedingChapter

Dornfeld, KJ & Skildum, AJ 2018, Mitochondria remodeling in cancer. in Mitochondrial Biology and Experimental Therapeutics. Springer International Publishing, pp. 153-191. https://doi.org/10.1007/978-3-319-73344-9_9
Dornfeld KJ, Skildum AJ. Mitochondria remodeling in cancer. In Mitochondrial Biology and Experimental Therapeutics. Springer International Publishing. 2018. p. 153-191 https://doi.org/10.1007/978-3-319-73344-9_9
Dornfeld, Kenneth J. ; Skildum, Andrew J. / Mitochondria remodeling in cancer. Mitochondrial Biology and Experimental Therapeutics. Springer International Publishing, 2018. pp. 153-191
@inbook{396d2275a03643959b1987a08556412e,
title = "Mitochondria remodeling in cancer",
abstract = "Cancer cells are characterized by altered metabolism and uncontrolled proliferation. It is not surprising that mitochondria, which serve important roles in fuel oxidation (catabolism) and synthesizing biosynthetic precursors (anabolism), are altered in cancer cells. Although most cancer cells have increased uptake of glucose and upregulation of glycolysis, mitochondria remain essential for carcinogenesis. However, cancer cell mitochondria have significant differences that distinguish them from those of normal cells. Mitochondria of cancer cells often have decreased electron transport capacity, depressed ATP generation, and increased production of reactive oxygen species. These alterations in metabolism promote nutrient uptake, support increased proliferation and afford resistance to apoptotic cell death. The specific metabolic processes in cancer provide opportunities to selectively target them pharmacologically to improve outcomes for cancer patients. In cancer diagnosis, tumor metabolism can be inferred from gene expression patterns and mutations, rates of nutrient uptake, and from direct measurement of metabolites. In treatment, these processes can be specifically targeted. Alterations in metabolism, mitochondrial DNA, the electron transport chain, and tricarboxylic acid cycle enzymes in cancer are described. The exploitation of these differences for diagnosis and treatment are discussed, with a review of select agents currently in clinical use or under active investigation.",
keywords = "Anabolism, Cancer, Chemotherapy, Glycolysis, Tricarboxylic acid cycle, Warburg",
author = "Dornfeld, {Kenneth J.} and Skildum, {Andrew J}",
year = "2018",
month = "3",
day = "21",
doi = "10.1007/978-3-319-73344-9_9",
language = "English (US)",
isbn = "9783319733432",
pages = "153--191",
booktitle = "Mitochondrial Biology and Experimental Therapeutics",
publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Mitochondria remodeling in cancer

AU - Dornfeld, Kenneth J.

AU - Skildum, Andrew J

PY - 2018/3/21

Y1 - 2018/3/21

N2 - Cancer cells are characterized by altered metabolism and uncontrolled proliferation. It is not surprising that mitochondria, which serve important roles in fuel oxidation (catabolism) and synthesizing biosynthetic precursors (anabolism), are altered in cancer cells. Although most cancer cells have increased uptake of glucose and upregulation of glycolysis, mitochondria remain essential for carcinogenesis. However, cancer cell mitochondria have significant differences that distinguish them from those of normal cells. Mitochondria of cancer cells often have decreased electron transport capacity, depressed ATP generation, and increased production of reactive oxygen species. These alterations in metabolism promote nutrient uptake, support increased proliferation and afford resistance to apoptotic cell death. The specific metabolic processes in cancer provide opportunities to selectively target them pharmacologically to improve outcomes for cancer patients. In cancer diagnosis, tumor metabolism can be inferred from gene expression patterns and mutations, rates of nutrient uptake, and from direct measurement of metabolites. In treatment, these processes can be specifically targeted. Alterations in metabolism, mitochondrial DNA, the electron transport chain, and tricarboxylic acid cycle enzymes in cancer are described. The exploitation of these differences for diagnosis and treatment are discussed, with a review of select agents currently in clinical use or under active investigation.

AB - Cancer cells are characterized by altered metabolism and uncontrolled proliferation. It is not surprising that mitochondria, which serve important roles in fuel oxidation (catabolism) and synthesizing biosynthetic precursors (anabolism), are altered in cancer cells. Although most cancer cells have increased uptake of glucose and upregulation of glycolysis, mitochondria remain essential for carcinogenesis. However, cancer cell mitochondria have significant differences that distinguish them from those of normal cells. Mitochondria of cancer cells often have decreased electron transport capacity, depressed ATP generation, and increased production of reactive oxygen species. These alterations in metabolism promote nutrient uptake, support increased proliferation and afford resistance to apoptotic cell death. The specific metabolic processes in cancer provide opportunities to selectively target them pharmacologically to improve outcomes for cancer patients. In cancer diagnosis, tumor metabolism can be inferred from gene expression patterns and mutations, rates of nutrient uptake, and from direct measurement of metabolites. In treatment, these processes can be specifically targeted. Alterations in metabolism, mitochondrial DNA, the electron transport chain, and tricarboxylic acid cycle enzymes in cancer are described. The exploitation of these differences for diagnosis and treatment are discussed, with a review of select agents currently in clinical use or under active investigation.

KW - Anabolism

KW - Cancer

KW - Chemotherapy

KW - Glycolysis

KW - Tricarboxylic acid cycle

KW - Warburg

UR - http://www.scopus.com/inward/record.url?scp=85046051111&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85046051111&partnerID=8YFLogxK

U2 - 10.1007/978-3-319-73344-9_9

DO - 10.1007/978-3-319-73344-9_9

M3 - Chapter

SN - 9783319733432

SP - 153

EP - 191

BT - Mitochondrial Biology and Experimental Therapeutics

PB - Springer International Publishing

ER -